Yesterday, EndoChoice Holdings Inc (NYSE:GI) that it entered a definitive agreement to be acquired by Boston Scientific for $8 per share, a total …
In a research report issued yesterday, William Blair analyst Margaret Kaczor reiterated an Outperform rating on Zeltiq Aesthetics (NASDAQ:ZLTQ). No price was target …